MetLife (MET)
(Delayed Data from NYSE)
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
Zacks News
Aflac (AFL) Rides on Strength at U.S and Japan Segments
by Zacks Equity Research
Aflac (AFL) is well poised for growth on the back of a rebound in top-line growth and other strategic measures
What's in the Cards for Marsh & McLennan (MMC) Q3 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter results are likely to reflect better revenues and a solid contribution from its Risk and Insurance Services segment.
Will MetLife (MET) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
MetLife (MET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Prudential (PRU) Establishes Retirement Strategies Business
by Zacks Equity Research
Prudential's (PRU) Prudential Retirement Strategies bring together Individual Annuities business and Retirement Institutional Investment Products.
Reasons Why Investors Should Retain EverQuote (EVER) Stock
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from improvements in traffic volumes and monetization, improved performance of automotive insurance providers and robust capital position.
MetLife (MET) Ups Stake in PNB Metlife to Boost India Presence
by Zacks Equity Research
MetLife (MET) inks deal to purchase combined stake of IGE and Elpro in PNB MetLife. With increased stake in India's JV, the company intends to bolster its presence in India.
Zacks.com featured highlights include: Academy Sports and Outdoors, M/I Homes, MetLife, ArcelorMittal and Nu Skin Enterprises
by Zacks Equity Research
Zacks.com featured highlights include: Academy Sports and Outdoors, M/I Homes, MetLife, ArcelorMittal and Nu Skin Enterprises
MET or PUK: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MET vs. PUK: Which Stock Is the Better Value Option?
7 Low Price-to-Sales Stocks for Value-Focused Investors
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like SIG, GIII, NUS, MET, MT, MOS and HIBB are promising picks.
Pick These 5 Bargain Stocks With Alluring EV-to-EBITDA Ratios
by Anindya Barman
We have screened bargain stocks ASO, MHO, MET, MT and NUS based on EV-to-EBITDA ratio that offers a clearer picture of valuation and earnings potential.
Top 5 Financial Stocks to Tap Higher Government Bond Yields
by Nalak Das
We have narrowed down our search to five large-cap insurers that have strong growth potential for the rest of 2021. These are: AFL, AFG, MET, FNF and MKL.
MetLife (MET) Arm Ties Up to Boost Digital Suite in Bangladesh
by Zacks Equity Research
MetLife's (MET) unit MetLife Bangladesh joins forces with Citi to offer a H2H payment processing platform to help customers make online premium payments.
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Assurant (AIZ) Gains 17% YTD: Can It Retain the Momentum?
by Zacks Equity Research
Strong performing Global Lifestyle business, growing the fee-based capital-light businesses and solid capital management continue to drive Assurant (AIZ).
MET vs. PUK: Which Stock Is the Better Value Option?
by Zacks Equity Research
MET vs. PUK: Which Stock Is the Better Value Option?
3 Value Picks From the Undervalued Multiline Insurance Space
by Tanuka De
Leveraging solid fundamentals and adopting technological advancements to increase operational efficiency amid optimistic economic growth outlook, undervalued multiline insurers MET, HIG, ORI are poised to fetch better return.
7 Low Price-to-Sales Stocks to Buy in the Current Market
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like FL, GIII, NUS, MET, PIPR, HIBB, and SMP are promising picks.
Prudential (PRU) to Sell Variable Annuity to Fortitude Re
by Zacks Equity Research
Prudential (PRU) agrees to sell its in-force legacy variable annuity block to Fortitude Re for $2.2 billion.
Here's Why You Should Add MetLife (MET) to Your Portfolio Now
by Zacks Equity Research
MetLife (MET) continues to benefit from solid returns stemming from its private equity portfolio, diversified product suite and robust capital position.
AIG's Unit Joins SIMON's Platform, Boosts Annuity Portfolio
by Zacks Equity Research
AIG's unit, AIG Life & Retirement, joins SIMON's platform aimed to extend reach of the former's annuity suite to several U.S. financial professionals.
Here's Why You Should Hold Prudential Financial (PRU) Stock
by Zacks Equity Research
Prudential Financial (PRU) continues to benefit from lower expenses, higher earnings from joint venture investments, positive third-party net flows, and prudent capital deployment.
Why Aflac (AFL) Should be Part of Your Investment Portfolio
by Zacks Equity Research
Aflac (AFL) is a promising bet for strong returns, given its reviving sales at the U.S and Japan segments and long-term strategic initiatives.
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is it the Right Time to Add Horace Mann (HMN) to Your Kitty?
by Zacks Equity Research
Horace Mann Educators Corporation (HMN) is poised to gain from niche focus, demographic shift and strategic acquisition.
MetLife (MET) Up 4.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.